Breakthrough: new guidance for silent cerebral ischemia and infarction in sickle cell disease

Area of Science:

• Neurology
• Hematology
• Pediatrics

Background:

• Silent cerebral infarction (SCI) is a frequent and serious complication in sickle cell disease (SCD).
• SCI incidence increases with age, beginning in infancy.
• Anemia and blood pressure are identified as potentially modifiable risk factors for SCI.

Purpose of the Study:

• To review the prevalence, risk factors, and implications of SCI in pediatric SCD.
• To discuss the impact of SCI on cognition and the role of socioeconomic factors.
• To highlight the significance of acute silent cerebral ischemic events in understanding the total brain injury burden in SCD.

Main Methods:

• Literature review and synthesis of existing research on SCI in SCD.
• Analysis of risk factors including anemia, blood pressure, and headache.
• Discussion of cognitive outcomes and the interplay between biological and socioeconomic determinants.

Main Results:

• Headache is not reliably associated with SCI, suggesting screening MRI may not be necessary for neurologically normal children with headaches.
• SCI significantly impacts cognitive function, with socioeconomic factors playing a crucial role.
• Acute anemic events markedly elevate the risk of acute silent cerebral ischemic events and SCI.

Conclusions:

• The total burden of ischemic brain injury in SCD is greater than previously understood, with the identification of acute events.
• While medical management for SCI is undefined, diagnosis can facilitate access to resources for optimizing academic and vocational outcomes.
• Comprehensive interventions are essential for improving the long-term well-being of individuals with SCD and SCI.